Anticancer Therapies – Multimedia
Simple and Straightforward High-Throughput Proteomics Analysis With Michael Hinterberg
For this Teach Me in 10 episode we are joined by Michael Hinterberg from Soma Logic who provides an overview and inspiration for obtaining and analyzing high-dimensional proteomic data. He also shows how proteomic data are readily accessible for exploratory data analysis and hypothesis testing to those who are already familiar with genomic analysis or traditional statistics in other scientific fields.
Gut Bacteria Can Boost Response to Cancer Immunotherapy
A new study led by Scripps Research scientist Howard Hang, PhD, explains how and why a certain species of bacteria in the digestive tract significantly improves the tumor-fighting ability of approved cancer drugs known as checkpoint inhibitors.
Teach Me in 10 – What Can Proteomics Teach Us About Disease? With Dr. Clare Paterson
In this Teach Me in 10, we are joined by Dr. Clare Paterson from SomaLogic. Dr. Paterson discusses the power of proteomics, exploring how proteomics has evolved from assessments of single analytes to sensitive, specific and high throughput technologies capable of generating a wealth of invaluable data.
Opinionated Science Episode 34: Genetics of Endometriosis, the Birthing Brain and Cancer Vaccines
In this episode, the Technology Networks team reviews world-leading research into the mechanisms behind endometriosis, a condition that affects up to 10% of women of reproductive age, but often takes a decade to diagnose. There's also a peek into mom's brain during birth and a new cancer vaccine that harnesses similar technology used to create the Oxford–AstraZeneva COVID-19 vaccine.
Five Innovations in Cell-Based Therapy
Download this listicle to learn about recent advances in cell-based therapies including off-the-shelf chimeric antigen receptor (CAR) T-cell therapy, engineered T-cell receptor therapy and mesenchymal stem cell therapies.
Celebrating canSAR: The Largest Public Cancer Drug Discovery Resource in the World
Since its release in 2011, canSAR has become the largest, public, cancer drug discovery resource in the world. It brings together billions of pieces of experimental data across disciplines – biology, chemistry, pharmacology, structural biology, cell biology – with clinical insights.
Immunotherapy is a specific type of treatment that utilizes the body’s immune system to fight diseases such as cancer. Download this infographic to discover various types of immunotherapy and the potential of mRNA technology in this space.
Drug–Target Binding: Recent Research Developments
Being able to accurately predict drug–target interactions (DTIs) and drug–target binding affinity (DTBA) is crucial in early drug development and during drug repurposing endeavors. Here, we look at some recent research developments in this space.
Breast Cancer Treatment – Prof. Andrew Tutt on the OlympiA Trial
The results of the OlympiA clinical trial, involving ICR researchers, shows giving the drug olaparib for one year to breast cancer patients with inherited BRCA mutations, after they have completed initial treatment, reduced the chance of their breast cancer returning. Professor Andrew Tutt, Head of Breast Cancer Research at the ICR, explains more.
Key Developments in Cancer Immunotherapy Over the Last Decade
Download this list to explore current immunotherapeutic strategies, recent regulatory approvals and the future of cancer therapy.